Machine learning models classifiers enable a strong prediction of radioembolization-induced liver disease, and define a new bilirubin threshold for selection of patients
European Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.1007/s00259-026-07803-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Itzel Rivera und 8 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Rennes, CLCC Eugène Marquis, INSERM, LTSI - UMR 1099, Rennes, F-35000, France. Hauptthemen laut MEDLINE: Radioembolization, Therapeutic, Machine Learning, Bilirubin, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Région Bretagne, Eugene Marquis Comprehensive Cancer Center.
Abstract (Originalsprache)
PURPOSE: Selective Internal Radiotherapy (SIRT) is an established treatment option for hepatocellular carcinoma (HCC). However, a major complication is radioembolization-induced liver disease (REILD). METHODS: This retrospective study, analyzed patients treated with SIRT for HCC to identify clinical factors associated with REILD and to predict treatment response. Machine learning (ML) methods were applied to two distinct cohorts to determine predictors of toxicity and response. RESULTS: Among 138 patients analyzed for REILD, ML identified bilirubin as a key predictor. A refined threshold of 26.5 µmol/L (1.55 mg/dL) was associated with toxicity risk. In the response cohort (136 patients), predictive performance was limited, nevertheless tumor dose appeared as the most frequent feature selected by the models. CONCLUSIONS: Bilirubin was confirmed as a critical factor for REILD prediction with the identification of a new threshold that may improve patient risk stratification. While tumor dose appears as the main predictor of treatment outcome, robust response models require additional features.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ. Rennes, CLCC Eugène Marquis, INSERM, LTSI - UMR 1099, Rennes, F-35000, France.
- Department of Oncology, CLCC Eugène Marquis, Rennes, 35033, France.
- Department of Nuclear Medicine, CLCC Eugène Marquis, Rennes, 35033, France.
- Department of Oncology, CLCC Eugène Marquis, Rennes, 35033, France. j.edeline@rennes.unicancer.fr.
ORCID-Profile: Yan Rolland, Etienne Garin, Oscar Acosta, Julien Edeline
Förderung
- Région Bretagne
- Eugene Marquis Comprehensive Cancer Center
Zitieren
APA
Rivera, I., Bourien, H., Morel-Corlu, E., Peinoit, A., Le Sourd, S., Rolland, Y., Garin, E., Acosta, O., & Edeline, J. (2026). Machine learning models classifiers enable a strong prediction of radioembolization-induced liver disease, and define a new bilirubin threshold for selection of patients. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-07803-8
Vancouver
Rivera I, Bourien H, Morel-Corlu E, Peinoit A, Le Sourd S, Rolland Y, et al. Machine learning models classifiers enable a strong prediction of radioembolization-induced liver disease, and define a new bilirubin threshold for selection of patients. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-07803-8
BibTeX
@article{Rivera2026,
author = {Rivera, Itzel and Bourien, Heloïse and Morel-Corlu, Ewan and Peinoit, Alexandre and Le Sourd, Samuel and Rolland, Yan and Garin, Etienne and Acosta, Oscar and Edeline, Julien},
title = {Machine learning models classifiers enable a strong prediction of radioembolization-induced liver disease, and define a new bilirubin threshold for selection of patients},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.1007/s00259-026-07803-8}
}
EUVIMED